Instalab

Cashew Nut IgE Test

See whether your body is primed for a serious reaction to cashews, before the next bite finds out for you.

Who benefits from Cashew Nut IgE testing

Reacted After Eating Cashew
You had hives, swelling, vomiting, or trouble breathing after cashew and want to confirm whether it was a true allergic reaction.
A Parent of a Nut-Allergic Child
Your child has a known nut or food allergy and you want to know whether cashew and pistachio need to join the avoidance list.
Already Allergic to Pistachio
You react to pistachio and want to confirm the likely cross-reactivity to cashew before a surprise exposure happens.
Doing Oral Immunotherapy
You or your child are in or considering a cashew desensitization program and want to track how your immune response is shifting over time.

About Cashew Nut IgE

Cashew is one of the tree nuts most likely to cause severe, sometimes life-threatening allergic reactions, especially in children. Knowing whether your immune system has been primed to react is not a curiosity. It shapes what you put in your mouth, what you carry in your bag, and what your school or restaurant needs to know.

This test measures IgE (immunoglobulin E) antibodies in your blood that specifically recognize cashew proteins. A higher number means your immune system has become sensitized to cashew and is biologically capable of triggering an allergic response on exposure. A low or undetectable number strongly favors tolerance, but does not completely rule out a reaction.

What This Test Actually Measures

Cashew nut IgE (cashew-specific immunoglobulin E) is a blood antibody your immune system creates after it has decided that cashew proteins are a threat. It is measured in kUA/L, a unit describing how much allergen-specific antibody is bound per liter of serum. When cashew reaches tissue mast cells (immune cells in your tissues that store histamine) coated with this antibody, the cells release histamine and other chemicals that cause itching, hives, swelling, wheezing, vomiting, low blood pressure, and, in the most severe cases, anaphylaxis.

Two related tests exist. The standard cashew IgE test uses a whole cashew protein mixture and is sensitive but not very specific, meaning it flags many people who would not actually react to cashew. A more refined component test, Ana o 3 IgE, a component test targeting the 2S albumin storage protein in cashew, is more closely tied to true clinical allergy. Whenever possible, pair the two.

Why Cashew Reactions Deserve Their Own Test

Cashew is among the most severe tree nut allergens, frequently causing anaphylaxis in children. Reactions are often immediate and systemic, not just local mouth itching. A child with an undiagnosed cashew allergy can have a first severe reaction at a birthday party, a restaurant, or on a plane, which is why identifying sensitization ahead of time matters.

There is also strong cross-reactivity between cashew and pistachio, meaning a confirmed cashew allergy usually travels with a pistachio allergy. Less consistently, cross-reactivity has been reported with certain other tree nuts. A single test on cashew can therefore reframe how you think about an entire food category.

Elevated Levels and Allergic Disease

Higher levels of cashew-specific IgE, particularly Ana o 3, strongly raise the probability of a true, clinically relevant cashew allergy that would be confirmed by a supervised oral food challenge, the diagnostic gold standard where a person eats incremental doses under medical observation. In one pediatric cohort, an Ana o 3 IgE level around 2.0 kU/L corresponded to roughly a 95% probability of true cashew allergy, high enough that many specialists will diagnose allergy without putting the child through a risky food challenge.

Higher cashew IgE is also linked to greater likelihood of systemic and generalized reactions, including anaphylaxis. Monosensitization to Ana o 3 has been tied to severe reactions in particular. People with significant co-sensitization to multiple nut components tend to face broader avoidance needs and a higher overall burden of allergy.

What a Low or Negative Result Means

A very low Ana o 3 IgE has high specificity for tolerance and is used in clinical algorithms to avoid unnecessary food challenges. In a population-based cohort, Ana o 3 above 0.32 kUA/L yielded 95% specificity and 90% sensitivity, meaning values clearly below that threshold argue strongly against true allergy.

Low IgE is not a permission slip. Some people with clinically confirmed food allergy have undetectable food-specific IgE. If you have ever had symptoms after cashew, do not override that history based on a negative number alone. A negative test with a suggestive clinical story should still be evaluated by an allergist.

Cross-Reactivity: The Pistachio Connection

If your cashew IgE is elevated, assume pistachio is a concern until a specialist tells you otherwise. IgE to Ana o 3 has been shown to be highly predictive of both cashew and pistachio allergy, and cashew-pistachio co-allergy is the norm rather than the exception. Some cross-reactivity also appears with other tree nuts and with certain non-nut foods in the same botanical family, though clinical relevance varies and needs individual evaluation.

Reference Ranges From Published Research

Cashew IgE is an established clinical test, but the thresholds below are decision points from specific research studies, not universal targets. They come from pediatric cohorts using ImmunoCAP assays. Adults, different labs, and different assay platforms can report different numbers. Compare your result within the same lab over time, and pair it with a clinical history.

MarkerTierRangeWhat It Suggests
Cashew extract IgELow riskbelow about 0.1 kUA/LVery unlikely to have clinical cashew allergy
Cashew extract IgEIntermediateabout 0.1 to 8.5 kUA/LUnclear; further testing or oral food challenge often needed
Cashew extract IgEHigh riskat or above 8.5 kUA/LStrongly suggests true allergy; 95% specificity in one cohort
Ana o 3 IgELow riskbelow about 0.1 kUA/LFavors tolerance, high specificity for a negative result
Ana o 3 IgEHigh riskat or above about 0.32 kUA/L95% specificity and 90% sensitivity in a birth cohort
Ana o 3 IgEVery high riskat or above about 2.0 kU/LRoughly 95% probability of clinical cashew allergy in children

Source: pooled and individual pediatric cohorts, meta-analysis by Riggioni et al., Dang et al., Lange et al., and Brettig et al.

Tracking Your Trend

A single cashew IgE measurement captures one moment in a long story. Levels can change over years as children sometimes outgrow tree nut allergy, as tolerance is induced by treatment, or as sensitization evolves. One reading tells you the current state of your immune response. A trend tells you whether that response is stable, waning, or worsening.

Cashew-specific IgE and basophil reactivity tend to decrease during successful oral immunotherapy, a medically supervised program of eating increasing doses of the allergen, while allergen-specific IgG4 tends to rise. If you or your child are in such a program, serial cashew IgE (especially Ana o 3) is one of the tools specialists use to track the immune shift.

A reasonable cadence is to get a baseline, recheck in 6 to 12 months if there has been any change in symptoms or if immunotherapy is underway, and then at least every 1 to 2 years when under active management. Children with persistent high Ana o 3 IgE through adolescence are unlikely to outgrow cashew allergy and may benefit from more frequent monitoring tied to treatment decisions.

What to Do if Your Result Is Elevated

An elevated cashew IgE, especially with elevated Ana o 3, should push you toward three concrete actions. First, confirm the picture with an allergist who can interpret the number alongside your clinical history and, when needed, a supervised oral food challenge. Second, ask about testing for pistachio, given the near-inevitable cross-reactivity, and consider testing for other tree nuts if your history suggests broader reactivity. Third, get prescribed epinephrine auto-injectors, written allergy action plans, and review labeling and cross-contamination risks at home and when eating out.

A confirmed cashew allergy is not static. Emerging options include cashew oral immunotherapy, which can desensitize many cashew-allergic patients and cross-desensitize to pistachio, and anti-IgE biologics used in multi-food allergy settings. These are specialist-directed decisions, but your IgE numbers help shape the conversation.

When Results Can Be Misleading

A cashew IgE number can mislead in two common ways. A high whole-cashew extract IgE alongside a low Ana o 3 IgE can simply mean your immune system recognizes less dangerous, cross-reactive proteins (for example, from birch pollen or related botanicals) rather than the high-risk storage protein that actually drives severe reactions. In that pattern, the extract number looks scary, but reaction risk is lower than the headline suggests.

In the other direction, some people with true cashew allergy have very low or even undetectable cashew-specific IgE. Severe eczema, very high total IgE, recent use of systemic corticosteroids, or certain biologic therapies can also distort the interpretive context, even when assay interference is not the mechanism. If your clinical story and your test do not match, your story still counts. Ask an allergist to dig deeper.

What Moves This Biomarker

Evidence-backed interventions that affect your Cashew Nut IgE level

Decrease
Cashew oral immunotherapy, a supervised program of eating incrementally higher doses of cashew
This is the treatment most directly aimed at changing the underlying allergy, not just the number. Over months of specialist-supervised dosing, cashew-specific IgE tends to decrease and allergen-specific IgG4 tends to rise, paralleling clinical desensitization. In the NUT CRACKER cohort study, cashew oral immunotherapy desensitized most participants and cross-desensitized many to pistachio, with safety comparable to other food-based immunotherapy. The trade-off is that dosing itself carries a real risk of allergic reactions during the build-up phase.
MedicationModerate Evidence
Decrease
Omalizumab, an injectable anti-IgE biologic, used in multi-food allergy
Omalizumab binds free IgE and lowers how much antibody is available to trigger mast cells, effectively raising the threshold for allergic reactions to multiple foods including tree nuts. In a randomized trial of about 180 participants as young as 1 year old, 16 weeks of omalizumab was superior to placebo in increasing the amount of peanut and other common food allergens that could be tolerated without reaction. The drug does not cure the allergy, and reactions can resume if it is stopped.
MedicationModerate Evidence

Frequently Asked Questions

References

22 studies
  1. Lange L, Lasota L, Finger a, Vlajnic D, Büsing S, Meister J, Broekaert I, Pfannenstiel C, Friedrichs F, Price M, Trendelenburg V, Niggemann B, Beyer KAllergy2017
  2. Valk J, Gerth Van Wijk R, Vergouwe Y, Steyerberg E, Reitsma M, Wichers H, Savelkoul H, Vlieg-boerstra B, De Groot H, Dubois AE, De Jong NWClinical & Experimental Allergy2017
  3. Riggioni C, Ricci C, Moya B, Wong D, Van Goor E, Bartha I, Buyuktiryaki B, Giovannini M, Santos AFAllergy2023
  4. Dang T, Peters R, Neeland M, Brettig T, Green H, Mcwilliam V, Tang M, Dharmage S, Ponsonby a, Koplin J, Perrett KPediatric Allergy and Immunology2021